Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to collect OCT measurement data on normal healthy eyes.


Clinical Trial Description

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon DRI OCT Triton based on the percentile points for 1%, 5%, 95%, and 99%. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03067675
Study type Observational
Source Topcon Corporation
Contact
Status Completed
Phase
Start date March 1, 2017
Completion date September 30, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06071546 - Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology N/A
Completed NCT03080714 - Triton Agreement and Precision Study
Completed NCT03022383 - TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus
Completed NCT02982174 - Evaluation of the Signal to Noise Ratio at Various Retinal Layers
Withdrawn NCT02991027 - OCT Image Quality Performance Evaluation N/A
Active, not recruiting NCT04661124 - Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position